US 8338622
Heterocyclic compound
granted A61PA61P3/10A61P43/00
Quick answer
US patent 8338622 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P3/10, A61P43/00, A61P5/50